IL6 and COVID-19: Plasma levels of a vast array of inflammatory cytokines, some of which were associated with severity of clinical manifestations and more advanced disease requiring intensive care, are markedly elevated in patients with COVID-19 [35]; a condition of IL-6-dependent, impaired, immune cell cytotoxicity may contribute to abnormal immunoregulation caused by SARS-CoV-2 infection [24].